SC
CELG

Stralem & Co’s Celgene Corp CELG Stock Holding History

Stralem & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-69,903
Closed -$4.48M – 48
2018
Q4 		$4.48M Sell
69,903
-15,790
-18% -$1.17M 2.14% 31
2018
Q3 		$7.67M Sell
85,693
-6,625
-7% -$585K 2.28% 29
2018
Q2 		$7.33M Sell
92,318
-34,065
-27% -$2.83M 2.16% 33
2018
Q1 		$11.3M Sell
126,383
-8,860
-7% -$851K 2.24% 29
2017
Q4 		$14.1M Buy
135,243
+33,660
+33% +$3.8M 2.4% 27
2017
Q3 		$14.8M Sell
101,583
-33,822
-25% -$4.61M 2.13% 31
2017
Q2 		$17.6M Sell
135,405
-3,510
-3% -$430K 2.06% 32
2017
Q1 		$17.3M Sell
138,915
-10,759
-7% -$1.29M 2.02% 30
2016
Q4 		$17.3M Sell
149,674
-6,110
-4% -$680K 2.06% 31
2016
Q3 		$16.3M Buy
155,784
+2,600
+2% +$281K 1.89% 35
2016
Q2 		$15.1M Sell
153,184
-6,200
-4% -$641K 1.74% 35
2016
Q1 		$16M Sell
159,384
-15,630
-9% -$1.61M 1.74% 35
2015
Q4 		$21M Sell
175,014
-54,100
-24% -$6.26M 2.12% 33
2015
Q3 		$24.8M Sell
229,114
-41,110
-15% -$5.1M 2.06% 32
2015
Q2 		$31.3M Sell
270,224
-62,886
-19% -$7.19M 2.14% 32
2015
Q1 		$38.4M Sell
333,110
-190,883
-36% -$22.8M 2.14% 33
2014
Q4 		$58.6M Sell
523,993
-190,783
-27% -$20.1M 2.72% 21
2014
Q3 		$67.7M Sell
714,776
-212,100
-23% -$19.1M 2.72% 23
2014
Q2 		$79.6M Sell
926,876
-66,980
-7% -$5.09M 2.71% 24
2014
Q1 		$69.4M Sell
993,856
-80,676
-8% -$6.39M 2.19% 29
2013
Q4 		$90.8M Sell
1,074,532
-170,466
-14% -$13.5M 2.72% 26
2013
Q3 		$96M Sell
1,244,998
-215,364
-15% -$15.1M 2.92% 23
2013
Q2 		$85.4M Buy
+1,460,362
New +$87.9M 2.58% 27

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stralem & Co's CELG Position: Q1 2019 in Review

Stralem & Co sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 69,903 shares — an estimated $4.48M sold.

Stralem & Co first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $96M in Q3 2013. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Stralem & Co reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Stralem & Co sold 69,903 Celgene Corp shares in Q1 2019, an estimated $4.48M.
  • Stralem & Co first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Stralem & Co's Celgene Corp position peaked at $96M in Q3 2013.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Stralem & Co's 13F filing for Q1 2019, filed 17 Apr 2019.